Form 4: Airship AI Director Granted 20,000 Stock Options

Sentiment:

Insider Transaction Report


Airship AI Holdings, Inc. Director Peeyush Ranjan was granted 20,000 stock options with a $4.25 exercise price, vesting quarterly over four years.

Summary

  • Director Peeyush Ranjan of Airship AI Holdings, Inc. (AISP) was granted 20,000 stock options on September 3, 2025.
  • These newly granted options have an exercise price of $4.25 per share and are set to expire on September 3, 2035.
  • The 20,000 options will vest quarterly over a four-year period.
  • Ranjan also beneficially owns 9,767 shares of common stock directly.
  • Additionally, Ranjan holds 43,952 options with a $0.57 exercise price (expiring January 15, 2032) and 131,857 options with a $1.64 exercise price (expiring August 6, 2033), both received on December 21, 2023, as part of the company's merger agreement.
  • Ranjan holds 29,302 Earnout Rights, which are contingent on the achievement of specific operating performance and share price milestones, as well as continued service, under the Merger Agreement.

Sentiment

Score: 7

Explanation: The filing reports a routine equity grant to a director, which is generally positive for aligning interests but does not contain significant new operational or financial news to warrant a higher score. The future vesting and earnout potential are mildly positive.

Positives

  • The grant of 20,000 stock options to Director Peeyush Ranjan aligns his interests with long-term shareholder value, as the options vest over four years and have an exercise price of $4.25.
  • The existence of earnout rights for 29,302 shares indicates potential future share issuance tied to the company's operating and share price performance, incentivizing management to achieve specific milestones.

Risks

  • The value of the newly granted options and existing options is subject to the future performance of Airship AI's common stock.
  • Earnout Rights are contingent on the Reporting Person's continued service and the achievement of specific operating performance and share price milestones, meaning their realization is not guaranteed.

Future Outlook

The grant of 20,000 stock options with a four-year vesting schedule indicates a long-term incentive for Director Peeyush Ranjan, aligning his future compensation with the company's sustained performance and growth. The earnout rights also tie future share issuance to specific operating and share price milestones, suggesting a performance-driven outlook for the company.

Industry Context

This filing reflects standard corporate governance practices where directors receive equity compensation to align their interests with shareholders. The vesting schedule and performance-based earnout rights are common mechanisms used in the technology and AI sectors to incentivize long-term commitment and performance from key personnel, especially following a merger or acquisition event.

Comparison to Industry Standards

  • The grant of stock options with multi-year vesting is a standard practice for director compensation in publicly traded technology companies, comparable to practices at firms like Palantir Technologies or C3.ai, which use equity to attract and retain top talent and align incentives.
  • The inclusion of earnout rights tied to operational and share price performance is a common feature in merger agreements, particularly in high-growth sectors, to ensure post-merger integration success and value creation, similar to earnout structures seen in acquisitions within the software or AI industry.

Stakeholder Impact

  • Shareholders: The grant of options to a director aligns management's interests with long-term shareholder value, potentially leading to better performance. However, future exercise of options could lead to minor dilution.
  • Management: Director Peeyush Ranjan receives additional equity incentives, strengthening his stake in the company's success.

Next Steps

  • The 20,000 newly granted options will vest quarterly over the next four years, starting from September 3, 2025.
  • The Earnout Rights will convert to common stock upon the achievement of specified operating performance and share price milestones during applicable earnout periods.

Key Dates

DateDescription
2023-06-27Date of the original Merger Agreement between Airship AI Holdings, Inc. (formerly BYTE Acquisition Corp.) and Airship AI, Inc.
2023-09-22Date of amendment to the Merger Agreement.
2023-12-21Date when options to purchase common stock were received by Peeyush Ranjan pursuant to the Merger Agreement.
2025-09-03Date of the transaction for the grant of 20,000 stock options to Peeyush Ranjan.
2025-09-04Date the Form 4 was signed by Peeyush Ranjan.
2032-01-15Expiration date for 43,952 options with a $0.57 exercise price.
2033-08-06Expiration date for 131,857 options with a $1.64 exercise price.
2035-09-03Expiration date for the newly granted 20,000 options with a $4.25 exercise price.

Recommendation

hold

This Form 4 filing details a routine equity grant to a director, which is a standard compensation practice aimed at aligning management incentives with shareholder interests. While positive for governance, it does not provide new material information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment thesis. Therefore, a 'hold' recommendation is appropriate as the filing itself does not present a compelling reason to buy or sell based solely on this information.

Keywords

Airship AI Holdings, AISP, Peeyush Ranjan, Stock Options, Director Compensation, SEC Form 4, Insider Ownership, Equity Grant, Merger Agreement, Earnout Rights

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.